Get started
Author

Zhongyuan Li

ORCID: 0000-0002-8642-5581
Observed ORCIDs: 0000-0002-8642-5581, 0009-0001-5318-4814
OpenAlex ID: A5032350921
A novel bispecific antibody CVL006 superior to AK112 for dual targeting of PD-L1 and VEGF in cancer therapy
2025 · Chunyan Wang, Hao Huang, et al. · Antibody Therapeutics · 11
PDF
Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer
2024 · Qiushi Jia, Fulin Li, et al. · Drug Delivery and Translational Research · 10
Self-Assembled Gd/Cyanine Nanoplatform for Magnetic Resonance Imaging Guided Photothermal Therapy of Thyroid Cancer
2025 · Changzhi Guo, Fulin Li, et al. · ACS Applied Nano Materials · 3
Preparation and MRI Study of HER2‐Targeted Bimodal Molecular Probe Gd‐Cy5.5‐Pertuzumab for Thyroid Cancer
2022 · Hongda Tian, Jinren Liu, et al. · Contrast Media & Molecular Imaging · 3
PDF
Abstract 4736: A highly selective CDK4/9 dual inhibitor reverses tumor resistance to CDK4/6 inhibitors
2025 · Jinwen Huang, Zhongyuan Li, et al. · Cancer Research · 1
Abstract 835: A potent and selective small molecule inhibitor of CD38
2025 · Jinwen Huang, Zhongyuan Li, et al. · Cancer Research · 1
Correction: Human epidermal growth factor receptor 2(Her2)-targeted pH-responsive MR/NIRF bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer
2024 · Qiushi Jia, Fulin Li, et al. · Drug Delivery and Translational Research · 1
PDF
Biomimetic nanoplatform remodels tumor hypoxia for enhanced chemo-photothermal therapy of anaplastic thyroid cancer
2026 · Fulin Li, Shuai He, et al. · Colloids and Surfaces A Physicochemical and Engineering Aspects
Abstract 5123: C018, a potent and selective CDK4&9 dual inhibitor
2026 · Jinwen Huang, Zhongyuan Li, et al. · Cancer Research
Study on the inhibition of thyroid undifferentiated carcinoma metastasis by nanoparticles loaded with EZH2 inhibitor
2026 · Shuang Wu, Changzhi Guo, et al. · Translational Cancer Research
Nontargeted metabolomics analysis of potential biomarkers for patients with chronic ischemic stroke in extremely cold rural regions: An exploratory case-control study
2026 · Li Bai, Zhongyuan Li, et al. · PLoS ONE
PDF
pH-Responsive Proteomimetic Nanodelivery System for the Diagnosis and Treatment of Anaplastic Thyroid Carcinoma
2025 · Qiushi Jia, Jianing Song, et al. · NANO
Works count: 12
Citation count: 30
H-index: 3
I10-index: 2
Year
Topic
Type